Liver disease

Osteopontin induces ductular reaction contributing to liver fibrosis
Xiaodong Wang, Aritz Lopategi, Xiaodong Ge, Yongke Lu, Naoto Kitamura, Raquel Urtasun, Tung-Ming Leung, Maria Isabel Fiel, Natalia Nieto

Gut Nov 2014, 63 (11) 1805-1818; DOI: 10.1136/gutjnl-2013-306373
Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma
Jessica Liu, Hwai-I Yang, Mei-Hsuan Lee, Sheng-Nan Lu, Chin-Lan Jen, Richard Batrla-Utermann, Li-Yu Wang, San-Lin You, Chuhsing K Hsiao, Pei-Jer Chen, Chien-Jen Chen

Gut Oct 2014, 63 (10) 1648-1657; DOI: 10.1136/gutjnl-2013-305785
HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability
Gi-Ae Kim, Young-Suk Lim, Jihyun An, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee, Dong Jin Suh

Gut Aug 2014, 63 (8) 1325-1332; DOI: 10.1136/gutjnl-2013-305517
LB-004 Balance Of Roles For Distinct Cd1d-reactive ‘nkt’ Cell Populations In Th1-type Anti-viral And Th2 Pro-fibrotic Responses In Viral Hepatitis
M Exley

Gut Jun 2014, 63 (Suppl 1) e2; DOI: 10.1136/gutjnl-2014-307263.LB4
PTH-078 Forward Progress Or Financial Extravagance? Counting The Cost Of Nice Guidelines For Chronic Hepatitis B
B Hudson, H Badham, TY Lim, H Morrison, CA McCune, AJ Portal, PL Collins, FH Gordon

Gut Jun 2014, 63 (Suppl 1) A243-A244; DOI: 10.1136/gutjnl-2014-307263.524
PTH-080 Risk Profile For Non-alcoholic Fatty Liver Disease (nafld) In A Paediatric Specialist Care Setting
FWD Tai, Y Derwa, S Naik, W Alazawi

Gut Jun 2014, 63 (Suppl 1) A244-A245; DOI: 10.1136/gutjnl-2014-307263.526
PTH-082 Do Serum Markers Of Cell Injury And Death Have Potential To Become Mechanistic Markers In Non-alcoholic Fatty Liver Disease (nafld)?
JI Grove, DJ Antoine, P Kaye, MH Miller, JF Dillon, ME Allison, MW James, EA Wilkes, AP Jackson, IN Guha, DP Williams, GP Aithal

Gut Jun 2014, 63 (Suppl 1) A245-A246; DOI: 10.1136/gutjnl-2014-307263.528
PTH-081 Enhanced Liver Fibrosis (elf) Test Performs Better Than Histological Parameters In Predicting Clinical Outcomes In Patients With Advanced Fibrosis Due To Chronic Hepatitis C Infection
GE Dolman, A Zaitoun, WL Irving, NI Guha

Gut Jun 2014, 63 (Suppl 1) A245; DOI: 10.1136/gutjnl-2014-307263.527
PTH-084 Nutritional Impact Of Anti-viral Therapy Of Genotype 1 Hepatitis C Patients
J Bennett, K Young, P Dundas, S English, L Mcleman, B Vijayan, A Fraser, A Mukhopadhya

Gut Jun 2014, 63 (Suppl 1) A246-A247; DOI: 10.1136/gutjnl-2014-307263.530
PTH-085 Systematic Review Of Performance Of Alt In Predicting Liver Fibrosis: Alt Is A Sensitive, But Not A Specific Marker Of Liver Fibrosis In Populations With/suspected Liver Disease
J Coad, S Olsen, W Rosenberg, P Roderick, J Parkes

Gut Jun 2014, 63 (Suppl 1) A247; DOI: 10.1136/gutjnl-2014-307263.531

Main menu

Liver disease

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Liver disease

Pages